I don't dispute the evidence the Mastitis is a $50 billion dollar global problem. The key question is what revenue POH can realistically expect to generate?
Anyone that has followed bio companies know they all engage in the the 'it's a xx billion dollar market' game, but the revenue available to them is only a fraction of that "potential" What do people think POH can generate in its first year (Sep 11 - Sep 12)? I doubt they could do more than $1m at best.
it`s the balance sheet stupid, page-47
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(16.7%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $2.099K | 707.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 85992113 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 63266804 | 17 |
View Market Depth
| Last trade - 15.59pm 30/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |